RADNET INC

NASDAQ: RDNT (RadNet, Inc.)

最近更新时间: 10 Nov, 5:10PM

72.53

1.13 (1.58%)

前收盘价格 71.40
收盘价格 71.56
成交量 780,650
平均成交量 (3个月) 523,106
市值 5,364,122,624
市盈率 (P/E TTM) 402.94
价格/销量 (P/S) 3.19
股市价格/股市净资产 (P/B) 6.53
52周波幅
28.62 (-60%) — 72.69 (0%)
利润日期 10 Nov 2024
营业毛利率 -0.25%
营业利益率 (TTM) 7.71%
稀释每股收益 (EPS TTM) -0.070
季度收入增长率 (YOY) 14.70%
季度盈利增长率 (YOY) -81.70%
总债务/股东权益 (D/E MRQ) 155.12%
流动比率 (MRQ) 2.16
营业现金流 (OCF TTM) 279.41 M
杠杆自由现金流 (LFCF TTM) 83.03 M
资产报酬率 (ROA TTM) 2.39%
股东权益报酬率 (ROE TTM) 3.20%

市场趋势

短期 中期
行业 Diagnostics & Research (US) 混合的 混合的
Diagnostics & Research (全球的) 混合的 混合的
股票 RadNet, Inc. 看涨 看涨

AIStockmoo 评分

0.5
分析师共识 3.0
内部交易活动 NA
价格波动 -0.5
技术平均移动指标 0.0
技术振荡指标 -0.5
平均 0.50

相关股票

股票 市值 DY P/E(TTM) P/B
RDNT 5 B - 402.94 6.53
MEDP 10 B - 29.56 12.42
GH 4 B - - 55.67
VCYT 3 B - - 2.69
NEO 2 B - - 2.32
MYGN 1 B - - 1.64

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

部门 Healthcare
行业 Diagnostics & Research
投资方式 Small Growth
内部持股比例 10.62%
机构持股比例 87.19%
52周波幅
28.62 (-60%) — 72.69 (0%)
目标价格波幅
85.00 (17%) — 100.00 (37%)
100.00 (Jefferies, 37.87%) 购买
94.00 (29.60%)
85.00 (Barclays, 17.19%) 购买
平均值 93.00 (28.22%)
总计 3 购买
平均价格@调整类型 80.59
公司 日期 目标价格 调整类型 价格@调整类型
Jefferies 05 Dec 2024 100.00 (37.87%) 购买 79.16
Barclays 04 Dec 2024 85.00 (17.19%) 购买 80.86
Truist Securities 29 Nov 2024 94.00 (29.60%) 购买 81.76
23 Sep 2024 80.00 (10.30%) 购买 71.10

该时间范围内无数据。

日期 类型 细节
04 Dec 2024 公告 Ketryx Announces DeepHealth Selected Its Software to Accelerate AI-Powered Health Informatics Innovation
02 Dec 2024 公告 RadNet’s Wholly-Owned Subsidiary, DeepHealth, Launches New AI-powered Informatics and SmartTechnology™ Innovations at #RSNA2024
02 Dec 2024 公告 RadNet, Inc. to Present at the BofA Securities 2024 Leveraged Finance Conference on December 3, 2024
01 Dec 2024 公告 Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™
01 Dec 2024 公告 Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet
01 Dec 2024 公告 RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New AI Control System for Clinical AI Performance and Safety
29 Nov 2024 公告 RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
22 Nov 2024 公告 RadNet Secures Commitments to Amend its Credit Facility, Resulting in 0.25% Reduction in Interest Rates
11 Nov 2024 公告 GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
11 Nov 2024 公告 GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
10 Nov 2024 公告 RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA⁽¹⁾ and Revises Upwards 2024 Financial Guidance Ranges
07 Nov 2024 公告 RadNet’s DeepHealth, Inc. Signs First Customer Commitment to Deploy a Suite of Solutions Powered by DeepHealth OS
25 Oct 2024 公告 RadNet, Inc. Announces Date of its Third Quarter 2024 Financial Results Conference Call
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2024 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票